findmyKOL
Clinical trialNCT00626236CompletedPhase 2Interventional

Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems

SponsorSupernus Pharmaceuticals, Inc.Enrollment78Attention Deficit Disorder With HyperactivityConduct Disorder
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Florida Clinical Research Center

    Bradenton, Florida, United States

  • Sarkis Clinical Trials

    Gainesville, Florida, United States

  • Cns Healthcare

    Orlando, Florida, United States

  • Capstone Clinical Research

    Libertyville, Illinois, United States

  • the Psychopharm Research Cntr - Lsu Dept of Psychiatry

    Shreveport, Louisiana, United States

  • Ips Research

    Oklahoma City, Oklahoma, United States

  • Clinical Neuroscience Solutions, Inc.

    Memphis, Tennessee, United States

  • Alliance Research Group

    Richmond, Virginia, United States

  • Northwest Clinical Trials

    Bellevue, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
21 Oct 2008
Primary completion
23 Sept 2009
Completion
23 Sept 2009
Last update posted
9 Dec 2025
Registered enrollment
78
Registry id
NCT00626236

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.